Quantification of microenvironmental metabolites in murine cancer models reveals determinants of tumor nutrient availability by Sullivan et al.
Cancer metabolism: what can we learn from analysing metabolites in tumour infiltrating fluid rather than in blood plasma?
Selected by Maria Rafaeva. Read the preLight here
Mechanical Stretch Kills Transformed Cancer Cells by Tijore et al.
Forcefully aiming at cancer cells.
Selected by Vibha Singh. Read the preLight here
A metabolic switch from OXPHOS to glycolysis is essential for cardiomyocyte proliferation in the regenerating heart by Honkoop et al.
Heart regeneration: Cardiomyocytes need to undergo a metabolic switch in order to re-enter the cell cycle.
Selected by Andreas van Impel. Read the preLight here
A schizophrenia risk gene, NRGN, bidirectionally modulates synaptic plasticity via regulating the neuronal phosphoproteome by Hongik Hwang
Hwang et al. show neurogranin regulates CaM-Ca2+ levels and phosphatase activity in the post-synaptic compartment and influences synaptic plasticity.
Selected by Laura McCormick. Read the preLight here
A conserved MFS orchestrates a subset of O-glycosylation to facilitate macrophage dissemination and tissue invasion by Valoskova et al.
Minerva instructs Drosophila embryonic macrophages to push the boundaries of tissue invasion by initiating a developmentally controlled program of glycosylation.
Selected by Giuliana Clemente. Read the preLight here
Applications of Machine Learning in Decision Analysis for Dose Management for Dofetilide by Levy et al.
AND
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer
by Schneider et al.
Where dosing dreams are born: Developments in drug toxicity modelling and reinforcement learning in optimising drug dosing regimens.
Selected by Zhang-He Goh. Read the preLight here
Bacteriophage resistance alters antibiotic mediated intestinal expansion of enterococci by Chatterjee et al.
Resistance is futile: Phage therapy used with antibiotics to combat enterococci in a dysbiotic microbiota.
Selected by Yasmin Lau. Read the preLight here
Tracking the popularity and outcomes of all bioRxiv preprints by Abdill & Blekhman
What makes preprints popular? preLighters respond to a meta-analysis of bioRxiv preprints.
Read the preLight here
- © 2019. Published by The Company of Biologists Ltd
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Editor’s Choice – Mild maternal hyperglycemia in INSC93S transgenic pigs causes impaired glucose tolerance and metabolic alterations in neonatal offspring
Simone Renner and colleagues used a transgenic pig model to show that mild hyperglycemia in insulin-mutant mothers results in poorer glucose tolerance and metabolic disturbances in the offspring, even wild-type ones.
In their article and accompanying poster, Martina Konantz and colleagues summarize the last 20 years of research in zebrafish models for hematopoietic disorders, highlighting how these models were created and are being applied for translational research.
A new Resource article from Susanne Sattler’s group describes a refined MRI technique to quantify acute hemorrhagic myocarditis in mice.
Have you seen our interviews with the early-career first authors of our papers? Recently, we caught up with Karishma Chhabria, Eleftheria Pervolaraki, Tamio Furuse, Hiroshi Mizuma, Katja Graf, Antonia Last and Monika Tomecka.
DMM joins the Review Commons initiative
Disease Models & Mechanisms is pleased to be a part of the new and exciting Review Commons initiative, launched by EMBO and ASAPbio. Streamlining the publishing process, Review Commons enables high-quality peer review to take place before journal submission. Papers submitted to Review Commons will be assessed independently of any journal, focusing solely on the paper’s scientific rigor and merit.
preLights – preLights reaches 500 posts!
The success of preLights is down to the hard work of our preLighters. Head over to the preLights website to find out more about our most active early-career-researchers.